BigClassActions.com
Advertisement

Psychiatric Solutions Inc, PSYS Securities Stock Fraud

- by

Company: Psychiatric Solutions Inc,
Ticker Symbol: PSYS
Class Period: Feb-21-08 to Feb-25-09
Date Filed: Sep-21-09
Lead Plaintiff Deadline: Nov-20-09
Court: Middle District of Tennessee
Allegations:
A class action lawsuit has been commenced on behalf of an institutional investor in the United States District Court for the Middle District of Tennessee on behalf of purchasers of Psychiatric Solutions, Inc ("Psychiatric Solutions") common stock during the period between February 21, 2008 and February 25, 2009 (the "Class Period").

The complaint charges Psychiatric Solutions and certain of its officers and directors with violations of the Securities Exchange Act of 1934. Psychiatric Solutions provides inpatient behavioral healthcare services.

The complaint alleges that during the Class Period, defendants issued materially false and misleading statements concerning the Company's safeguards and controls over its operations, including at its Riveredge Hospital ("Riveredge") facility. Defendants downplayed incidents at the Company's facilities, indicating that the deficiencies had all been resolved. Defendants assured investors that corrective actions had already been taken at the Company's facilities to improve the quality, safety and risk management. Additionally, defendants issued materially false and misleading statements regarding the Company's financial results and compliance with Generally Accepted Accounting Principles. Specifically, the Company failed to properly account for its contingent liabilities related to the deficiencies surrounding its operations. As a result of defendants' false and misleading statements, Psychiatric Solutions stock traded at artificially inflated prices during the Class Period, reaching a high of $39.71 per share on July 8, 2008.

On February 20, 2008, the beginning of the Class Period, Psychiatric Solutions issued its 2007 financial results, increasing earnings guidance for 2008. Just over a week later, the Company filed its Form 10-K for 2007, representing it had "higher quality care" than its competitors and assuring that Psychiatric Solutions was in compliance with applicable government regulations.

On July 17, 2008, the Chicago Tribune ("Tribune") issued an investigative report which disclosed unreported violence among juvenile patients at the Company's Riveredge facility. As a result of the Tribune's investigation, the Illinois Department of Children and Family Services ("DCFS") placed a hold on admitting youths in the custody of the state to Riveredge. As a further result, the Department of Justice initiated an investigation into the facility and its operations.

Then, on February 25, 2009, Psychiatric Solutions announced disappointing fourth quarter and year-end financial results due to the problems at Riveredge. The Company missed its 2008 income guidance from continuing operations of $2.02 to $2.03 per diluted share, instead reporting $1.92 per diluted share. The guidance miss was based upon the problems at the Company's Riveredge facility, including the effect of the continuing hold at the facility by DCFS, additional charges related to the investigation and an increase in the Company's general and professional liability reserves. On this news, Psychiatric Solutions' stock fell $9.79 per share to close at $17.50 per share on February 26, 2009, a 1-day decline of 35%.

If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

Psychiatric Solutions Inc, PSYS Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible Psychiatric Solutions Inc, securities class action lawsuit. Please fill in our form on the right to submit your complaint for a free evaluation.

Maybe it's your stockbroker

Add Your Comment on This Issue

Fields marked * are mandatory. Please read our comment guidelines before posting.

*Name:

Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment:
Request Legal Help